Tango Therapeutics Inc. (TNGX) Live Share Price, Invest From India

Tango Therapeutics Inc. Stock Performance

as on July 14, 2026 at 2:16 pm IST

Day's Low
Day's High
$28.25
Day's Price Range
$30.77
$28.36
0.39%
Downside
8.50%
Upside
52 Week's Low
52 Week's High
$5.77
52-Week Price Range
$34.39
$28.36
79.65%
Downside
21.26%
Upside

Tango Therapeutics Inc. share price movements today

Previous Close: $31.06
Open: $30.53
Volume: 2.1M
Day's Low - High: $28.25 - $30.77
52 Week Low - High: $5.77 - $34.39

Tango Therapeutics Inc. Historical Returns

1 Month Return: -8.34 %
3 Month Return: + 17.87 %
1 Year Return: + 365.68 %
3 Year Return: + 726.82 %
5 Year Return: 0 %

Tango Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Tango Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.1B

EPS (TTM)

-1.3091

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-115.4M

Revenue (TTM)

57.0M

Profit Margin

-188.15%

Return On Equity TTM

-38.42%

Tango Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tango Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tango Therapeutics Inc.	BUY	$5.1B	NA	NA	-188.15%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.9B	69.11%	75.25	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.2B	142.69%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$69.7B	14.12%	16.24	29.65%	0.54%

Stock Returns calculator for Tango Therapeutics Inc. Stock including INR - Dollar returns

The Tango Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tango Therapeutics Inc. investment value today

Current value as on today

₹5,17,646

Returns

₹4,17,646

(+417.65%)

Returns from Tango Therapeutics Inc. Stock

₹3,65,681 (+365.68%)

Dollar Impact

₹51,965 (+51.96%)

Analyst Recommendation on Tango Therapeutics Inc. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Tango Therapeutics Inc.. Average target price of $43.82

Tango Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Tango Therapeutics Inc..

What analysts predicted

35.28%UPSIDE

Target Price

$43.82

Current Price

$28.36

Analyzed by

14 Analysts

Target

$43.82

Tango Therapeutics Inc. target price $43.82, a slight upside of 35.28% compared to current price of $28.36. According to 14 analysts rating.

Indian Investors' Interest in Tango Therapeutics Inc. Stock

Search interest for Tango Therapeutics Inc. Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 14, 2026 to July 14, 2026

Change:-42% versus previous 30 day period

Tango Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	5	6	19	11	4	5	3	53	-	-
Gross Profit	5	6	19	11	4	5	2	53	0	0
Operating Income	-35	-42	-29	-32	-40	-42	-40	14	-41	-48
EBITDA	-30	-37	-24	-28	-37	-39	-38	16	-38	-45
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-30	-37	-25	-29	-37	-39	-38	15	-38	-45
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-30	-37	-25	-29	-37	-39	-38	15	-38	-45
Net Profit Margin	-566.43%	-585.91%	-128.56%	-251.29%	-914.99%	-739.54%	-1221.41%	29.52%	0.00%	0.00%

Tango Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	24	7	37	24	36	42	62
Gross Profit	-7	6	37	24	36	42	60
Operating Income	-15	-52	-58	-111	-114	-145	-111
EBITDA	-14	-50	-57	-109	-99	-127	-99
Interest Expense	-	-	1	2	-	-	-
Depreciation	-	0	0	1	2	2	2
Income Before Tax	-14	-51	-57	-108	-101	-130	-101
Income Tax Expense	-	0	0	0	0	0	0
Net Income	-14	-51	-58	-108	-101	-130	-101
Net Profit Margin	-57.18%	-678.84%	-157.21%	-435.14%	-278.54%	-309.73%	-162.85%

Tango Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-37	-25	-29	-37	-39	-38	15	-38	-45
Operating Cash Flow	-37	-23	-33	-36	-41	-36	-30	-29	-44
Investing Cash Flow	-11	12	32	52	30	16	47	-135	9
Financing Cash Flow	42	1	2	0	0	0	2	219	79
Change in Cash	-6	-9	1	16	-11	-19	19	53	45

Tango Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-51	-58	-108	-101	-130	-101
Operating Cash Flow	70	-59	-109	-117	-131	-138
Investing Cash Flow	-145	-183	26	41	86	-40
Financing Cash Flow	80	357	1	82	47	222
Change in Cash	5	114	-81	5	2	42

Global Institutional Holdings in Tango Therapeutics Inc.

Funds	Holdings
TRV GP IV, LLC	4.41%
RA Capital Management, LLC	1.8%
Point72 Asset Management, L.P.	2.05%
State Street Corp	3.22%
Deerfield Management Co	2.87%

See all

Insights on Tango Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, TNGX stock has moved up by 150.7%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TNGX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 3.18M → 53.81M (in $), with an average increase of 94.1% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TNGX has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 15.88M → -45.51M (in $), with an average decrease of 180.7% per quarter

About Tango Therapeutics Inc.

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Organisation	Tango Therapeutics Inc.
Headquarters	201 Brookline Avenue, Boston, MA, United States, 02215
Industry	Biotechnology
CEO	Dr. Malte Peters M.D.
E-voting on shares	Click here to vote

Key Management of Tango Therapeutics Inc.

Name	Title
Ms. Elizabeth Pingpank Hickin	VP of IR & Corporate Communications
Dr. Barbara L. Weber M.D.	Founder & Executive Chairman of the Board
Dr. Malte Peters M.D.	President, CEO & Director
Prof. Alan Ashworth FRS, Ph.D.	Founder & Member of Scientific Advisory Board
Dr. Antoni Ribas M.D., Ph.D.	Founder & Member of Scientific Advisory Board
Mr. Jannik N. Andersen Ph.D.	Chief Scientific Officer
Ms. Daniella Beckman CPA	Executive Officer
Dr. Adam S. Crystal M.D., Ph.D.	President of Research & Development
Dr. William G. Kaelin Jr., M.D.	Founder & Member of Scientific Advisory Board
Mr. Matthew Gall M.B.A.	Chief Financial Officer

FAQs

What is Tango Therapeutics Inc. share price today?

Tango Therapeutics Inc. share price today is $28.36 as on July 14, 2026 at 8:46 am IST at the close of the market. Tango Therapeutics Inc. share today touched a day high of $30.77 and a low of $28.25.

What is the 52 week high and 52 week low for Tango Therapeutics Inc. share?

Tango Therapeutics Inc. share touched a 52 week high of $34.39 on June 17, 2026 and a 52 week low of $5.77 on August 1, 2025. Tango Therapeutics Inc. stock price today i.e. July 14, 2026 at 8:46 am IST is closed at $28.36,which is 17.53% down from its 52 week high and 391.51% up from its 52 week low.

What is Tango Therapeutics Inc.'s market capitalisation today?

Tango Therapeutics Inc. market capitalisation is $0.01T as on July 14, 2026 at 8:46 am IST.

How to invest in Tango Therapeutics Inc. Stock (TNGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tango Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tango Therapeutics Inc. Shares that will get you 0.0529 shares as per Tango Therapeutics Inc. share price of $28.36 per share as on July 14, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tango Therapeutics Inc. Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics Inc. (TNGX) shares with as little as ₹95.615 or $1 (as of July 14, 2026 at 4:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in Tango Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 14, 2026 at 4:37 pm IST). Based on Tango Therapeutics Inc. share’s latest price of $28.36 as on July 14, 2026 at 8:46 am IST, you will get 0.3526 shares of Tango Therapeutics Inc.. Learn more about fractional shares .